Revolution Medicines (RVMD) Amortizatization of Intangibles (2019 - 2026)

Revolution Medicines' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 67.17% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $21.2 million (down 45.74% YoY), while the FY2025 annual figure was $27.8 million, down 37.55% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $3.2 million, down from $4.6 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $15.2 million in Q1 2024, with the low at -$648000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $5.1 million (2023), against an average of $5.9 million.
• The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles jumped 18066.67% in 2023, then plunged 67.17% in 2026.
• Revolution Medicines' Amortizatization of Intangibles stood at $2.6 million in 2022, then surged by 233.06% to $8.6 million in 2023, then advanced by 2.24% to $8.8 million in 2024, then plunged by 48.4% to $4.6 million in 2025, then decreased by 29.23% to $3.2 million in 2026.
• Business Quant data shows RVMD's Amortizatization of Intangibles at $3.2 million in Q1 2026, $4.6 million in Q4 2025, and $5.7 million in Q3 2025.